SODIUM POLYSTYRENE SULFONATE
SODIUM POLYSTYRENE SULFONATE for suspension
Approved
Approval ID
fd9b192f-51f3-4737-be14-1970327f39aa
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2023
Manufacturers
FDA
Belcher Pharmaceuticals, LLC
DUNS: 965082543
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SODIUM POLYSTYRENE SULFONATE
PRODUCT DETAILS
NDC Product Code62250-660
Application NumberANDA205727
Marketing CategoryC73584
Route of AdministrationORAL, RECTAL
Effective DateOctober 5, 2023
Generic NameSODIUM POLYSTYRENE SULFONATE
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR